| Name | Title | Contact Details |
|---|
Founded in 2016, Huupe is the first-ever smart basketball hoop. It brings competition and training to basketball enthusiasts and players, including NBA athletes as well as stars from the league who have invested in the company. Huupe`s groundbreaking innovation enables ages eight and up to compete on the court or virtually, learn and improve their skills, track their progress, and more. The appointment of Paul as CTO follows the company`s 400% growth month over month in the past six months this year, with 50% growth in October 2022 alone, and viral popularity on social media.
Giuseppe Space Enterprises is a company that specializes in the implementation, integration, and optimization of various tools and technologies into standardized system engineering/integration processes and workflows. They are committed to advancing th...
KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.
C-TASC provides products and services to support responsible management of clinical trials, clinical surveys, case/control studies, clinical registries, clinical cohort studies and laboratory studies. For over 15 years C-TASC's services group has played nearly every role in studies of all sizes. Our experienced and professional medical and biostatistical staff can provide expertise in complete study design, data collection and management and data analysis. C-TASC's software group has developed, hosted and managed Web-based clinical data management systems for dozens of studies including the recent release of our SaaS product StudyCTMS.com, an end-to-end clinical trials management system (CTMS) including electronic data capture (EDC), integrated SAS, a drag and drop form builder and many other intuitive tools. StudyCTMS.com is an affordable solution for every investigator. Our location is convenient to Washington DC, Maryland, Philadelphia, and Southern New Jersey.
Dental Art Laboratory Inc is a Lansing, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.